世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の顧みられない熱帯病(NTD)治療市場 2017-2027年

Global Treatment for Neglected Tropical Disease Market 2017-2027

Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease

 

出版社 出版年月価格 ページ数図表数
Visiongain
ヴィジョンゲイン社
2017年9月お問い合わせください 157 151

サマリー

Report Details

The Global Treatment for Neglected Tropical Disease market is expected to grow at a CAGR of 7.3% in the second half of the forecast period. The Global Treatment for Neglected Tropical Disease market reached $1.5bn in 2016, dominated by the treatments for malaria which held 30% share of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 157-page report you will receive 71 tables and 80 figures– all unavailable elsewhere.

The 157-page report provides clear detailed insight into the Global Treatment for Neglected Tropical Disease market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Treatment for Neglected Tropical Disease market forecasts from 2017-2027

• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by disease type:
- Malaria treatments
- Dengue treatments
- Leishmaniasis
- Schistosomiasis
- Lymphatic Filariasis
- Chagas Disease
- Others

For each disease type, the report provides a SWOT analysis, a list of selected drugs and revenue forecasts from 2017-2027 of the leading drugs.

• This report provides revenue forecast for these leading drugs:
- Coartem (Novartis)
- Clindamycin (Pfizer)
- Dengvaxia (Sanofi)
- AmBisome (Gilead Sciences)
- Impavido (Knight Therapeutics)
- ALBENZA (Amedra Pharmaceuticals LLC)

• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by regional and national market:
- North America: US and Canada
- Europe: Germany, the UK, France, Spain, Italy, Rest of Europe
- Asia-Pacific: Japan, China, India, Rest of Asia
- Latin America: Brazil, Mexico, Rest of Latin America
- Middle East & Africa: Saudi Arabia, South of Africa, Rest of Middle East & Africa

Each regional market is further broken down by disease type.

• This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the neglected tropical disease market:
- Pfizer, Inc.
- Bayer
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis International AG
- Takeda Pharmaceutical Company Ltd
- Sanofi S.A.
- Eisai Co., Ltd

Buy our report today Global Treatment for Neglected Tropical Disease Market 2017-2027: Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease.



目次

Table of Contents

1. Report Overview
1.1 Global Treatment for Neglected Tropical Disease Market Overview
1.2 Overview of Findings
1.3 Structure of the Report
1.4 Global Treatment for Neglected Tropical Disease Market Segmentation
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. Introduction to Treatment for Neglected Tropical Disease
2.1 An Introduction to Treatment for Neglected Tropical Disease
2.2. Malaria Treatments
2.3. Dengue Treatments
2.4. Leishmaniasis
2.5 Schistosomiasis
2.6 Lymphatic Filariasis
2.7 Chagas Disease
2.8. Drivers
2.8.1. Increasing prevalence of various neglected tropical disease
2.8.2. Product Launch and Government Initiatives
2.9. Restrains
2.9.1 High Possibilities of Side Effect of Vaccine

3. Global Treatment for Neglected Tropical Disease Market 2017-2027
3.1 Global Treatment for Neglected Tropical Disease Market Forecast 2017-2027
3.2 Changing Market Shares by Segment2017-2027
3.3 Global Malaria Treatments Segment Market: Sales Forecast 2017-2027
3.3.1. Leading Drugs in the Malaria Treatments Market
3.3.1.1. Coartem (Novartis)
3.3.1.2. Clindamycin (Pfizer, Inc.)
3.3.1.3. Other Malaria Drugs
3.3.2. SWOT Analysis of the Malaria Treatments Market, 2017-2027
3.3.2.1. Strength
3.3.2.1.1. Supportive Government policy for Primary Health Care strategies
3.3.2.2. Weakness
3.3.2.2.1. Inadequacies in public health infrastructure, including training facilities
3.3.2.3. Opportunity
3.3.2.3.1. Increasing prevalence of Malaria
3.3.2.4. Threat
3.3.2.4.1. Community resistance to surveillance activities
3.4 Global Dengue treatments Segment Market: Sales Forecast 2017-2027
3.4.1. Dengvaxia (Sanofi)
3.4.2. SWOT Analysis of the Dengue Treatments Market, 2017-2027
3.4.2.1. Strength
3.4.2.1.1. Approval of Dengvaxia
3.4.2.2. Weakness
3.3.2.2.1. Vaccine is not available worldwide
3.4.2.3. Opportunity
3.4.2.3.1. Increasing prevalence of Dengue
3.4.2.4. Threat
3.4.2.4.1. Side Effects of Dengvaxia
3.5 Global Leishmaniasis Segment Market: Sales Forecast 2017-2027
3.5.1. AmBisome (Gilead Sciences)
3.5.2. Impavido (Marketed by Knight Therapeutics)
3.5.3. Leishmaniasis Drugs
3.5.4. SWOT Analysis of the Leishmaniasis Market, 2017-2027
3.5.4.1. Strength
3.5.4.1.1. Availability of vaccines
3.5.4.2. Weakness
3.5.4.2.1. No or less prevalence in developed regions
3.5.4.3. Opportunity
3.5.4.3.1. Increasing Prevalence of Visceral leishmaniasis
3.5.4.4. Threat
3.5.4.4.1. Patient don’t know if they are infected
3.6 Global Schistosomiasis Segment Market: Sales Forecast 2017-2027
3.6.1. SWOT Analysis of the Schistosomiasis Market, 2017-2027
3.6.1.1. Strength
3.6.1.1.1. Increasing prevalence of Schistosomiasis
3.6.1.2. Weakness
3.6.1.2.1. No or less prevalence in North America and Europe
3.6.1.3. Opportunity
3.6.1.3.1. Major patient base in Middle East & Africa
3.6.1.4. Threat
3.6.1.4.1. New Entrants
3.7 Global Lymphatic Filariasis Segment Market: Sales Forecast 2017-2027
3.7.1. ALBENZA (Amedra Pharmaceuticals LLC)
3.7.2. Lymphatic Filariasis Drugs
3.7.3. SWOT Analysis of the Lymphatic Filariasis Market, 2017-2027
3.7.3.1. Strength
3.7.3.1.1. Increasing number of patient treated with lymphatic filariasis
3.7.3.2. Weakness
3.7.3.2.1. Availability of vaccine for the patients
3.7.3.3. Opportunity
3.7.3.3.1. Increasing prevalence of Lymphatic Filariasis
3.7.3.4. Threat
3.7.3.4.1. Side Effects of ALBENZA
3.8 Global Chagas Disease Segment Market: Sales Forecast 2017-2027
3.8.1. Chagas Disease Drugs
3.8.2. SWOT Analysis of the Chagas Disease Market, 2017-2027
3.8.2.1. Strength
3.8.2.1.1. Increasing prevalence rate of underdiagnosed migrants
3.8.2.2. Weakness
3.8.2.2.1. Low prevalence of Chagas Disease in Asia-Pacific and Middle East & Africa
3.8.2.3. Opportunity
3.8.2.3.1. Increasing prevalence of Chagas Disease
3.8.2.4. Threat
3.8.2.4.1. Neglected by market players
3.9 Global Others Segment Market: Sales Forecast 2017-2027

4.Leading National Markets 2017-2027
4.1 Geographical Breakdown of the World Treatment for Neglected Tropical Disease Market
4.2 World Treatment for Neglected Tropical Disease Market: Regional Forecast 2017-2027
4.2.1 How Will Regional Market Shares Change to 2027?

5. North America Treatment for Neglected Tropical Disease Market 2017-2027
5.1. U.S. Treatment for Neglected Tropical Disease Market: Trends and Developments
5.2. Canada Treatment for Neglected Tropical Disease Market: Trends and Developments

6. Europe Treatment for Neglected Tropical Disease Market 2017-2027
6.1. Germany Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.2. France Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.3. U.K. Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.4. Italy Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.5. Spain Treatment for Neglected Tropical Disease Market Forecast 2017-2027
6.6. Rest of Europe Treatment for Neglected Tropical Disease Market Forecast 2017-2027

7. Asia-Pacific Treatment for Neglected Tropical Disease Market 2017-2027
7.1. China Treatment for Neglected Tropical Disease Market: Trends and Developments
7.2. Japan Treatment for Neglected Tropical Disease Market: Trends and Developments
7.3. India Treatment for Neglected Tropical Disease Market: Trends and Developments
7.4. Rest of Asia-Pacific Treatment for Neglected Tropical Disease Market: Trends and Developments

8. Latin America Treatment for Neglected Tropical Disease Market 2017-2027
8.1 Brazil Treatment for Neglected Tropical Disease Market: Trends and Developments
8.2. Mexico Treatment for Neglected Tropical Disease Market: Trends and Developments
8.3. Rest of Latin America Treatment for Neglected Tropical Disease Market: Trends and Developments

9. Middle East and Africa Treatment for Neglected Tropical Disease Market 2017-2027
9.1. Saudi Arabia Treatment for Neglected Tropical Disease Market Forecast 2017-2027
9.2. South Africa Treatment for Neglected Tropical Disease Market Forecast 2017-2027
9.3. Rest of Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast 2017-2027

10. Leading Companies in the Treatment for Neglected Tropical Disease Market
10.1. Pfizer, Inc.
10.1.1 Pfizer, Inc.: Treatment for Neglected Tropical Disease Product Portfolio
10.1.2 Pfizer, Inc.: Financial Overview
10.1.3 Pfizer, Inc.: Recent Developments
10.2. Bayer AG
10.2.1 Bayer AG: Treatment for Neglected Tropical Disease Portfolio
10.2.2 Bayer AG: Financial Overview
10.2.3 Bayer AG: Recent Transactions Summary
10.3. GlaxoSmithKline plc
10.3.1 GlaxoSmithKline plc: Treatment for Neglected Tropical Disease Portfolio
10.3.2 GlaxoSmithKline plc: Financial Overview
10.3.3 GlaxoSmithKline plc: Recent Transactions Summary
10.4. Merck & Co., Inc.
10.4.1 Merck & Co., Inc.: Treatment for Neglected Tropical Disease Portfolio
10.4.2 Merck & Co., Inc.: Financial Overview
10.4.3 Merck & Co., Inc.: Recent Transactions Summary
10.5. Novartis AG
10.5.1 Novartis: Treatment for Neglected Tropical Disease Product Portfolio
10.5.2 Novartis: Financial Overview
10.5.3 Novartis: Recent Developments
10.6. Takeda Pharmaceutical Company Ltd
10.6.1 Takeda Pharmaceutical Company Ltd: Treatment for Neglected Tropical Disease Product Portfolio
10.6.2 Takeda Pharmaceutical Company Ltd: Financial Overview
10.6.3 Takeda Pharmaceutical Company Ltd: Recent Developments
10.7. Sanofi S.A.
10.7.1 Sanofi S.A.: Treatment for Neglected Tropical Disease Product Portfolio
10.7.2 Sanofi S.A.: Financial Overview
10.7.3 Sanofi S.A.: Recent Developments
10.8. Eisai Co., Ltd
10.8.1 Eisai Co., Ltd: Treatment for Neglected Tropical Disease Product Portfolio
10.8.2 Eisai Co., Ltd: Financial Overview
10.8.3 Eisai Co., Ltd: Recent Developments

11. Conclusions
11.1 The World Treatment for Neglected Tropical Disease Market in 2016 and 2016
11.1.1 Current Leading Treatment for Neglected Tropical Disease Segments
11.1.2 Leading Regional Markets
11.2 World Treatment for Neglected Tropical Disease Market Forecast 2017-2027
11.3 The Future of the Treatment for Neglected Tropical Disease Market?

Appendices
Associated Visiongain Report
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form

List of Tables
Table 3.1 Global Treatment for Neglected Tropical Disease Market by Diseases Types: Revenue ($m) and Market Share (%), 2016
Table 3.2 Global Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.3 Global Malaria Treatments Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.4 Global Coartem Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.5 Global Clindamycin Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.6 Other Malaria Drugs
Table 3.7 SWOT Analysis of the Malria Market, 2017-2027
Table 3.8 Global Dengue Treatments Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.9 Global Dengvaxia Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.10 SWOT Analysis of the Dengue Treatment Market, 2017-2027
Table 3.11 Global Leishmaniasis Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.12 Global AmBisome Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.13 Global Impavido Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.14 Other Leishmaniasis Drugs
Table 3.15 SWOT Analysis of the Leishmaniasis Market, 2017-2027
Table 3.16 Global Schistosomiasis Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.17 SWOT Analysis of the Schistosomiasis Market, 2017-2027
Table 3.18 Global Lymphatic Filariasis Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.19 Global ALBENZA Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.20 Other Lymphatic Filariasis Drugs
Table 3.21 SWOT Analysis of the Lymphatic Filariasis Market, 2017-2027
Table 3.22 Global Chagas Disease Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 3.23 Other Chagas Disease Drugs
Table 3.24 SWOT Analysis of the Chagas Disease Market, 2017-2027
Table 3.25 Global Others Segment Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 4.1 Global Treatment for Neglected Tropical Disease Market by Region: Revenue ($m), 2016 and 2017
Table 4.2 Global Treatment for Neglected Tropical Disease Market Forecast, by Region: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 5.1 North America Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 5.2 North America Treatment for Neglected Tropical Disease Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %)
Table 5.3 U.S. Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 5.4 Canada Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.1 Europe Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 6.2 Europe Treatment for Neglected Tropical Disease Market Forecast, By Country: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 6.3 Germany Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.4 France Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.5 U.K. Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.6 Italy Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.7 Spain Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 6.8 Rest of Europe Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 7.1 Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 7.2 Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %)
Table 7.3 China Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 7.4 Japan Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 7.5 India Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 7.6 Rest of Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 8.1 Latin America Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 8.2 Latin America Treatment for Neglected Tropical Disease Market Forecast, By Country, 2016-2027 ($m, AGR %, CAGR %)
Table 8.3 Brazil Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 8.4 Mexico Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 8.5 Rest of Latin America Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 9.1 Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast, By Disease Type: Revenues ($m), AGR (%), CAGR (%), 2016-2027
Table 9.2 Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast, by Country 2016-2027 ($m, AGR %, CAGR %)
Table 9.3 Saudi Arabia Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 9.4 South Africa Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 9.5 Rest of MEA Treatment for Neglected Tropical Disease Market Forecast, 2016-2027 ($m, AGR %, CAGR %)
Table 10.1 Pfizer, Inc.: Overview, 2017
Table 10.2 Pfizer, Inc.: Revenue ($m), AGR (%), 2012-2016
Table 10.3 Bayer AG: Overview, 2017
Table 10.4 Bayer AG: Revenue ($m), AGR (%), 2012-2016
Table 10.5 GlaxoSmithKline plc: Overview, 2017
Table 10.6 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2012-2016
Table 10.7 Merck & Co., Inc.: Overview, 2017
Table 10.8 Merck & Co., Inc.: Revenue ($m), AGR (%), 2012-2016
Table 10.9 Novartis: Overview, 2017
Table 10.10 Novartis: Revenue ($m), AGR (%), 2012-2016
Table 10.11 Takeda Pharmaceutical Company Ltd: Overview, 2017
Table 10.12 Takeda Pharmaceutical Company Ltd: Revenue ($m), AGR (%), 2012-2016
Table 10.13 Sanofi S.A.: Overview, 2017
Table 10.14 Sanofi S.A.: Revenue ($m), AGR (%), 2012-2016
Table 10.15 Eisai Co., Ltd: Overview, 2017
Table 10.16 Eisai Co., Ltd: Revenue ($m), AGR (%), 2011-2015

List of Figure
Figure 1.1 Global Treatment for Neglected Tropical Disease Market Segmentation Overview
Figure 3.1 Global Treatment for Neglected Tropical Disease Market by Diseases Type: Market Share (%), 2016
Figure 3.2 Global Treatment for Neglected Tropical Disease Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.3 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2016
Figure 3.4 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2021
Figure 3.5 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2027
Figure 3.6 Global Malaria Treatments Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.7 Global Coartem Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.8 Global Clindamycin Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.9 Global Dengue Treatments Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.10 Global Dengvaxia Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.11 Global Leishmaniasis Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.12 Global AmBisome Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.13 Global Impavido Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.14 Global Schistosomiasis Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.15 Global Lymphatic Filariasis Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.16 Global ALBENZA Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.17 Global Chagas Disease Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 3.18 Global Others Segment Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 4.1 World Treatment for Neglected Tropical Disease Market: Revenues ($m) by Region, 2016
Figure 4.2 World Treatment for Neglected Tropical Disease Market: Revenues ($m) by Region, 2017
Figure 4.3 Global Treatment for Neglected Tropical Disease Market Forecast: Revenue ($m), AGR (%), 2016-2027
Figure 4.4 World Treatment for Neglected Tropical Disease Market: Market Shares (%) by Regional Market, 2016
Figure 4.5 World Treatment for Neglected Tropical Disease Market: Market Shares (%) by Regional Market, 2021
Figure 4.6 World Treatment for Neglected Tropical Disease Market: Market Shares (%) by Regional Market, 2027
Figure 5.1 North America Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 5.2 North America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
Figure 5.3 North America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
Figure 5.4 North America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
Figure 5.5 US Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 5.6 Canada Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.1 Europe Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.2 Europe Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
Figure 6.3 Europe Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
Figure 6.4 Europe Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
Figure 6.5 Germany Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.6 France Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.7 U.K. Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.8 Italy Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.9 Spain Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 6.10 Rest of Europe Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 7.1 Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 7.2 Asia-Pacific Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
Figure 7.3 Asia-Pacific Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
Figure 7.4 Asia-Pacific Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
Figure 7.5 China Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 7.6 Japan Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 7.7 India Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 7.8 Rest of Asia-Pacific Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 8.1 Latin America Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 8.2 Latin America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
Figure 8.3 Latin America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
Figure 8.4 Latin America Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
Figure 8.5 Brazil Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 8.6 Mexico Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 8.7 Rest of Latin America Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 9.1 Middle East and Africa Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 9.2 Middle East and Africa Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2016
Figure 9.3 Middle East and Africa Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2021
Figure 9.4 Middle East and Africa Treatment for Neglected Tropical Disease Market: Market Shares (%) by Country, 2027
Figure 9.5 Saudi Arabia Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 9.6 South Africa Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 9.7 Rest of MEA Treatment for Neglected Tropical Disease Market Forecast: Revenues ($m), AGR (%), 2016-2027
Figure 10.1 Pfizer, Inc.: Revenue ($m), AGR (%), 2012-2016
Figure 10.2 Pfizer, Inc.: National Revenue Share (%), 2016
Figure 10.3 Bayer AG: Revenue ($m), AGR (%), 2012-2016
Figure 10.4 Bayer AG: Business Segment Revenue Share (%), 2016
Figure 10.5 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2012-2016
Figure 10.6 GlaxoSmithKline plc: Business Segment Revenue Share (%), 2016
Figure 10.7 Merck & Co., Inc.: Revenue ($m), AGR (%), 2012-2016
Figure 10.8 Merck & Co., Inc.: Business Segment Revenue Share (%), 2016
Figure 10.9 Novartis: Revenue ($m), AGR (%), 2012-2016
Figure 10.10 Novartis: Revenue, by Region, Share (%), 2016
Figure 10.11 Takeda Pharmaceutical Company Ltd: Revenue ($m), AGR (%), 2012-2016
Figure 10.12 Takeda Pharmaceutical Company Ltd: Revenue, by Region, Share (%), 2016
Figure 10.13 Sanofi S.A.: Revenue ($m), AGR (%), 2012-2016
Figure 10.14 Sanofi S.A.: Revenue, by Region, Share (%), 2016
Figure 10.15 Eisai Co., Ltd: Revenue ($m), AGR (%), 2011-2015
Figure 11.1 Global Treatment for Neglected Tropical Disease Market by Disease Type: Market Share (%), 2016
Figure 11.2 Treatment for Neglected Tropical Disease Market, By Region Share (%), 2016, 2021, 2027

Companies Listed

Actiza Pharmaceutical
Amedra Pharmaceuticals LLC
APP Pharmaceuticals LLC
Asian Development Bank
Bayer
Bristol-Myers Squibb
Comic Relief
Cyper Pharma
Eisai Co., Ltd
F. Hoffmann-La Roche AG
Gilead Sciences
GlaxoSmithKline plc
Janssen
Johnson & Johnson
Kadmon Pharmaceuticals LLC
Knight Therapeutics
Merck
Nicholas Piramal India Ltd.
Novartis International AG
Pfizer, Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Ltd

List of Organizations Mentioned in The Report
Asia-Pacific Leaders Malaria Alliance (APLMA)
Australian Institute of Tropical Health and Medicine
Baylor College of Medicine
Centers for Disease Control and Prevention (CDC)
Department of Health Philippines
Drugs for Neglected Diseases Initiative (DNDi)
Emerging Infectious Diseases Journal (EID)
European Centre for Disease Control and Prevention (ECDC)
Eurosurveillance
Food and Drug Administration (FDA)
Global Health Innovative Technology Fund (GHIT Fund)
GOV.UK
International Cardiovascular Forum Journal
Liverpool School of Tropical Medicine
Malaria Journal
Malaysian Medical Association
Malaysian Pharmaceutical Society and Guardian Health & Beauty
Medicines for Malaria Venture
Ministry of Health – Kingdom of Saudi Arabia
Ministry of Health Malaysia
Ministry of Health, Labour and Welfare Japan
National Center for Biotechnology Information (NCBI)
National Vector Borne Disease Control Programme (NVBDCP)
Pan American Health Organization (PAHO)
Public Library of Science (PLOS)
Roll Back Malaria
The End Fund
The Gates Foundation
The United States Agency for International Development (USAID)
University of Liverpool
WHO Western Pacific Region (WPRO)
World Health Organization (WHO)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る